Showing results (1991-2000 of 10,003) with videos related to

Sort By:
Pageof 1,001
Leukemia & Lymphoma|April 4, 2022
Role of the bone marrow immune microenvironment in chronic myelomonocytic leukemia pathogenesis: novel mechanisms and insights into clonal propagationAbhishek A Mangaonkar, Mrinal M Patnaik
Leukemia & Lymphoma|January 14, 2016
SOX11 and HIG-2 are cross-regulated and affect growth in mantle cell lymphomaVenera Kuci, Lena Nordström, Paolo Conrotto, et al.
Leukemia & Lymphoma|January 14, 2016
Granulocyte colony-stimulating factor in secondary prophylaxis for advanced-stage Hodgkin lymphoma treated with ABVD chemotherapy: a cost-effectiveness analysisM C Cheung, A Prica, J Graczyk, et al.
Leukemia & Lymphoma|January 14, 2016
Quisinostat, bortezomib, and dexamethasone combination therapy for relapsed multiple myelomaPhilippe Moreau, Thierry Facon, Cyrille Touzeau, et al.
Leukemia & Lymphoma|January 15, 2016
Early immune recovery after autologous transplantation in non-Hodgkin lymphoma patients: predictive factors and clinical significanceJaakko Valtola, Ville Varmavuo, Antti Ropponen, et al.
Leukemia & Lymphoma|January 15, 2016
Prognostic impact of immunophenotypic complete response in patients with multiple myeloma achieving better than complete responseKota Fukumoto, Manabu Fujisawa, Yasuto Suehara, et al.
Leukemia & Lymphoma|December 23, 2015
The impact of pre-transplant minimal residual disease on outcome of intensified myeloablative cord blood transplant for acute myeloid leukemia in first or second complete remissionChangcheng Zheng, Xiaoyu Zhu, Baolin Tang, et al.
Leukemia & Lymphoma|December 23, 2015
Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imagingManisha Bhutani, Baris Turkbey, Esther Tan, et al.
Leukemia & Lymphoma|December 24, 2015
Prognostic relevance of DHAP dose-density in relapsed Hodgkin lymphoma: an analysis of the German Hodgkin-Study GroupStephanie Sasse, Magdalena Alram, Horst Müller, et al.
Leukemia & Lymphoma|December 25, 2015
Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with everolimus (RAD001) and alemtuzumab: a Phase I/II studyClive S Zent, Deborah A Bowen, Michael J Conte, et al.
Pageof 1,001